patients with any RMD while disease is moderately or severely active; this recommendation is based on extrapolated evidence that RMD disease activity increases pregnancy risks. For pregnancy planning, 6 months of stable inactive or lowlevel disease is most often suggested, but individual clinical factors may influence this decision. In patients with SLE, there is theoretical concern that ovarian stimulation with elevated estrogen levels may worsen active disease. We conditionally recommend